Kimura et al. [69] demonstrated that type 2 inflammation (IL-4 and IL-13) reduces ACE2 and increases TMPRSS2 expression in nasal and bronchial epithelial cells in asthma and atopy. The gene discussed is IL4; the disease is asthma.